Savaria Corp
TSX:SIS

Watchlist Manager
Savaria Corp Logo
Savaria Corp
TSX:SIS
Watchlist
Price: 30.04 CAD 2.56% Market Closed
Market Cap: CA$2.2B

Savaria Corp
Investor Relations

Savaria Corp. engages in the provision of accessibility solutions for the physically challenged individuals. The company is headquartered in Laval, Quebec and currently employs 1,605 full-time employees. The company went IPO on 2001-04-20. Its segments include Accessibility, Patient Handling and Adapted Vehicles. The Accessibility segment includes designing, manufacturing, distributing and installing a wide portfolio of products, including stairlifts for both straight and curved stairs, vertical and inclined wheelchair platform lifts for both commercial and residential applications, commercial accessibility elevators and home elevators. The Patient Handling segment includes the manufacturing and distributing of a comprehensive line of therapeutic support surfaces and other pressure management products for the medical market, medical beds for the long-term care market. The Adapted Vehicles segment consists of converting, adapting and distributing vehicles for people with mobility challenges, for personal or commercial use.

Show more
Loading
SIS
S&P TSX Composite Index (Canada)
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q4 2025
Call Date
Mar 5, 2026
AI Summary
Q4 2025

EBITDA milestone: Adjusted EBITDA reached $51.3 million in Q4 (21.2%) — the company's highest quarter ever — and full-year adjusted EBITDA was $186.2 million (20.4%).

Revenue: Consolidated Q4 revenue was $241.8 million and full-year sales were $913 million, with 8.3% revenue growth in the quarter (Accessibility +7.7%, Patient Care +10%).

Savaria One: Management says the continuous-improvement program is now embedded, delivering accelerating recurring savings (160+ initiatives in 2025) and more than 100 new initiatives planned for 2026.

Europe turnaround: Europe returned to positive organic growth in Q4; management rebranded European operations to Savaria and plans new product rollouts (stairlifts, incline platform lift, VPL) in 2026.

Capacity & US manufacturing: Greenville home-elevator expansion is underway (permit work, live likely in Q4 2026); management expects more US-made capacity to come online but will provide details later.

Balance sheet / M&A firepower: Liquidity is $312 million, net debt fell by $71 million YoY, ending leverage 1.03; company says it can invest roughly $200 million in acquisitions while keeping leverage below 2x.

Capital spend & taxes: 2025 capex was $22 million (2.4% of sales); 2026 capex expected ~2.5%–3% of sales (Greenville is a one-off driver); expected 2026 tax rate ~26%–26.5%.

Key Financials
Adjusted EBITDA (Q4)
$51.3 million
Adjusted EBITDA margin (Q4)
21.2%
Adjusted EBITDA (Full Year 2025)
$186.2 million
Sales (Full Year 2025)
$913 million
Consolidated revenue (Q4)
$241.8 million
Accessibility revenue growth (Q4)
7.7%
Patient Care revenue growth (Q4)
10%
Gross margin (Q4)
38.9%
Accessibility segment margin (Q4)
23.4%
Patient Care segment margin (Q4)
19.4%
Net earnings (Q4)
$20.5 million
Earnings per share (Q4)
$0.28
Operating income change (Q4)
increase of 36.6%
Cash flow from operating activities (Q4)
$35 million
Working capital reduction (Q4)
$2.8 million
Capital expenditures (Q4)
$6.8 million
Capital expenditures (Full Year 2025)
$22 million
CapEx guidance (2026)
approximately 2.5% to 3% of sales
CapEx plan (2027)
plan to return to ~2%–2.5% of sales
Finance costs (Q4)
$4.8 million
Interest on long-term debt change
decreased by $1.3 million
Unrealized foreign currency loss (Q4)
$1.7 million loss
Leverage ratio (ending 2025)
1.03
Net debt repayment (Q4 / Full Year 2025)
$45.2 million in Q4; $75.2 million for 2025
Available liquidity
$312 million
Acquisition capacity
$200 million over the next few years
Effective tax rate (guidance for 2026)
approximately 26%–26.5%
Earnings Call Recording
Other Earnings Calls

Management

Mr. Marcel Bourassa BAA
Executive Chairman
No Bio Available
Mr. Sebastien Bourassa
President, CEO & Director
No Bio Available
Mr. Stephen Reitknecht C.A., CPA
Chief Financial Officer
No Bio Available
Ms. Clare Brophy
President of EUROW Accessibility
No Bio Available
Mr. Les Teague
Group President of Patient Care
No Bio Available
Mr. Sylvain Aubry
Chief Legal Officer & Corporate Secretary
No Bio Available
Mr. Charles Nicolas Rimbert
Vice President of Corporate Development
No Bio Available
Ms. Laureen Cushing
Global Vice President of Human Resources
No Bio Available
Mr. Alexandre Bourassa
President of North America Accessibility
No Bio Available
Mr. Jean-Philippe De Montigny
Chief Transformation Officer
No Bio Available

Contacts

Address
QUEBEC
Laval
4350 Chomedey (A-13) W
Contacts
+14504379414.0
www.savaria.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett